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Objectives: Rheumatoid arthritis (RA) was found to trigger the higher risk of dementia.
Limited information, however, is available on whether the use of rehabilitation services
(RS), an integral part of healthcare programs, can lessen dementia risk for RA subjects.
The aim of this study was to determine the relationship of RS use to the development of
dementia in RA patients.
Methods: We identified 2,927 newly diagnosed patients with RA, 20–70 years of
age between 1998 and 2007, from a national health insurance database. 965 patients
from this sample received RS, and 1,962 patients were designated as a control group
(non-RS users). Patients were followed to the end of 2012 to identify dementia incident
as the end point. Cox proportional hazards regression was performed to calculate the
hazard ratio (HR) of dementia risk associated with the use of RS.
Results: During the study period, 388 patients with RS and 1,224 controls developed
dementia, representing incidence rate of 75.46 and 115.42 per 1,000 person-years,
respectively. After adjusting for potential confounders, RS was found to significantly
reduce dementia risk, with the adjusted HR of 0.60 (95% confidence interval [CI]
= 0.53–0.67). Those who used the high intensity of RS (≧15 courses) had the
greatest benefit.
Conclusions: Integrating RS into the conventional treatment may reduce the sequent
risk of dementia for RA patients.
Keywords: rheumatoid arthritis, dementia, rehabilitation, risk, cohort study
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KEY POINTS

blood pressure and lipid levels to prevent metabolic dysfunction,
all risk factors for cognitive impairment disorders (10). As such,
RS may provide a double benefit to patients with RA.
Although some studies have been conducted on RS needs
or utilization among patients with RA, the majority took
place in Western countries, and moreover, were limited to
either self-reported questionnaires or medical reviews, mainly
based on small samples (9, 11–13). In Taiwan, RS comprises
those services which relate to rehabilitative examination and
treatment, including occupational, physical, and communicative
interventions. These interventions are performed by only
qualified RS therapists, regardless of when the condition
occurred, and is practiced in outpatient clinics or inpatient wards.
A review of previous literature indicated that most studies of RS
in Taiwan have focused on RS utilization in patients with cancer,
hemophilia or traumatic brain injury (14–16). As of the present,
there have been no longitudinal cohort studies that focused on
the relationship between RS and the development of dementia
among RA patients. To narrow the gap between the research
questions, we used a nationwide population-based database to
compare the dementia risk among RA subjects who received or
did not receive RS.

- This is the first report from the nationwide representative
database to clarify the relation between RS and dementia risk
among RA patients.
- After analyses were controlled for potential confounders, the
use of RS was found to significantly reduce the sequent risk of
dementia, with the adjusted HR of 0.60 (95% CI = 0.53–0.67).
- This study further discovered that RA patients who used
the high-intensity RS (≧15 courses) had a 62% lower risk
of dementia.
- The findings of this study could guide healthcare providers to
more effective treatment strategies for RA patients.

INTRODUCTION
Rheumatoid arthritis (RA), an autoimmune inflammatory
arthritis disease, principally attacks the joints and affects
many bodily tissues and organs, thus causing significant
burden to both patients and their families through progressive
functional limitations and increased physical disability (1).
These phenomena together with the accompanying negative
effects often impede the work productivity of those with RA.
Approximately 20–30% of affected individuals are unable to
work within 3 years after RA onset (2), thus leading to the
enormous emotional and socioeconomic burden for patients,
their families and the healthcare system. It is estimated that the
medical expenses for one RA patient in the US is ∼US$20,919
per year, which was nearly three times higher than that for the
general population (3).
RA not only causes enormous economic burden but also
triggers other crippling illnesses. A systematic review of 15
studies found a positive association between RA and cognitive
impairment, such as dementia, a commonly-reported disorder
with advanced age (4). Similarly, a longitudinal study found that
those with autoimmune rheumatic disease, including a history
of RA, were significantly more likely than those without other
autoimmune rheumatic diseases to develop dementia over a
period of 12 years (5). Some scholars have concluded that the link
between RA and cognitive decline may be due to inflammation
in the brain (6). Further, the known high risk of cardiovascular
comorbidity of patients with RA may also be implicated in the
cognitive impairment (4).
Recently, rehabilitation service (RS) has been used as a
strategy to restore the functional independence and improve
psychophysical function in patients with RA (7, 8). One metaanalysis of six reports indicated that hydrotherapy can help
improve disease activity and health status (mood and tension)
for patients with RA compared to no intervention (P <
0.01) (9). Additionally, after reviewing 18 randomized control
trials that applied a physical activity-based intervention, and
adopting cognitive functioning as an outcome measure, the
authors found that physical exercise positively influenced global
cognitive functioning for patients affected by dementia (10). The
mechanism by which RS could lessen the risk of dementia was
that physical exercise, a core component of RS, can increase the
blood flow and oxygen supply to the brain, as well as decrease the
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METHODS
Data Source
The analytical data in this work were obtained from the
Longitudinal Health Insurance Database (LHID), which was
one of the subsets of the National Health Insurance Research
Database. LHID was made up of ∼1,000,000 randomly sampled
people and collected the corresponding medical records from
1996 to 2012 (17). The database has been confirmed by the
National Health Research Institute (NHRI) to be representative
of the Taiwanese population and its data has been used in other
published scientific papers (18, 19). The encrypted information
protects patient privacy and allows linkage of all claims for the
same patient within the database.

Ethics
This study was conducted according to the Declaration of
Helsinki and was approved by the institutional review board at
Buddhist Dalin Tzu Chi Hospital. The institutional review board
waived the need for informed consent (written and oral) from
the patients because the database utilized in this work consists of
nationwide, unidentifiable, secondary data released to the public
for research purposes (No. B10004021-3).

Study Population
In this work, to be designated as having a certain disease, the
subject had to have a corresponding code by the International
Classification of Disease, Ninth Revision, Clinical Modification
(ICD-9-CM) in the diagnosis field. We recruited patients aged
20–70 years who sought ambulatory healthcare services for RA
between 1998 and 2007 (ICD-9-CM code: 714.0). To ensure
the identification of RA patients, only those patients with
catastrophic illness certification due to RA were included in the
study. In Taiwan, insured citizen with major diseases, such as
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FIGURE 1 | Disposition of study subjects.

database. In this study, for the RS user group, the time period
between the date of RA diagnosis and the date of first RS use
after RA represented the immortal time, which would induce an
overestimation of the intervention’s beneficial effect. To reduce
this bias, we calculated person-years (PYs) starting from the
commencement of RS usage to correct for immortal time for the
subjects who received RS (22). The end date of the follow-up
period for both groups was defined as the earliest of a diagnosis
of dementia, withdraw from the insurance program, or the date
of December 31, 2012. Only dementia episodes which occurred
1 year after the index date were considered in establishing a
temporal link.

schizophrenia, mood disorders, immune disease, and cancer, can
obtain free care for their illness or related conditions within
the certificate’s validity period. We regarded the index date for
RA patients as the date on which they gained approval for
catastrophic illness registration. In order to confirm that all
patients with RA in this work were incident cases, only newonset RA cases were included (n = 5,581). Among them, a total of
2,419 patients diagnosed with dementia before the date of the first
RA attack were excluded. The diagnostic algorithm of dementia
required at least 3 outpatient visits, or at least one inpatient claim
for dementia (ICD-9-CM 290, 294, or 331) during the study
period. Also excluded were those with missing data and those
who were not followed for a full 6 months after RA diagnosis
(n = 235) (20). Overall, we identified 2,927 new-onset RA cases
(Figure 1).
Thereafter, all subjects were linked to the healthcare claims
data to determine RS usage following the onset of RA. Subjects
were considered RS users if their files indicated any recorded
fees for RS due to RA (14, 21). The remaining subjects were
classified as non-RS users. In Taiwan, under the National Health
Insurance (NHI) program, the RS include physical therapy,
occupational therapy, or speech therapy. RS therapists can apply
for compensation from the Bureau of NHI, and the total cost
regarding RS treatment is summed up and presented in the claim

Frontiers in Medicine | www.frontiersin.org

Definition of Covariates
Sociodemographic factors contained age, sex, monthly incomes,
and urbanization level of each patient’s residential area. Monthly
incomes were grouped into three levels: ≤New Taiwan Dollar
(NTD) $17,880, NTD$17,881–43,900, and ≥NTD$ 43,901.
Regarding the urbanization level, it was classified into seven
parts based on several dimensions, such as population density,
proportion of residents with college or higher education,
percentage of elderly (>65 years of age) people, proportion
of the workforce in agriculture, and number of physicians per
105 people (23). We further divided into three strata: urban
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demographic characteristics and comorbidities. To further test
the robustness of the association of RS use with dementia risk,
we categorized RS use as low intensity (1–3 courses), medium
intensity (4–14 courses), or high intensity (≧15 courses) based
on the former rule (16). A stratified analysis by age and sex
using Cox proportional hazards regression was also conducted
to assess the relative risk of dementia between the persons
who did and did not receive RS. We also used time-dependent
analysis with Cox proportional hazards regression to investigate
the risk of dementia in relation to the time-dependent effect of
RS. Additionally, log(-log[survival]) vs. log of survival time plot
was inspected to verify the proportional hazards assumption. All
analyses were conducted using SAS version 9.3 (SAS Institute
Inc., Cary, NC, USA) and a p-value below 0.05 was considered
statistically significant.

TABLE 1 | Demographic characteristics and comorbidities of persons with RA
who did and did not use RS.
Variable

Non-RS users

RS users

(n = 1962)

(n = 965)

49.57 (12.16)

50.11 (10.56)

≤50

986 (50.3)

463 (48.0)

>50

976 (49.7)

502 (52.0)

Female

1300 (66.3)

731 (75.8)

Male

662 (33.7)

234 (24.2)

Low

806 (41.1)

372 (38.5)

Median

1062 (54.1)

541 (56.1)

94 (4.8)

52 (5.4)

Urban

1113 (56.7)

605 (62.7)

Suburban

320 (16.3)

136 (14.1)

Rural

529 (27.0)

224 (23.2)

Age*
Age

0.24
0.25

Sex

<0.001

Monthly income

High

P

0.38

Residential area

0.001

Corticosteroid use

RESULTS
The study population consisted of 2,927 patients with RA (69.4%
women) with a mean ± standard deviation age of 49.9 2 ± 11.62
years. Among them, 1,962 patients did not receive RS and 965
did. Compared to non-RS users, those receiving RS were more
likely to be female, have heart disease, and reside in an urban area
(all p < 0.05) (Table 1).
Among all eligible patients with RA, a total of 1,662 first
episodes of dementia occurred, including 1,224 among non-RS
users and 388 among RS users, during the follow-up periods
of 10604.53 and 5141.98 person-years (PY), respectively. The
incidence rate of dementia was lower among RS users than in
non-RS users (75.46 vs. 115.42 per 1,000 PYs), and the adjusted
HR was 0.60 (95% CI = 0.53–0.67). Moreover, RA patients who
used the high intensity of RS had a 62% lower risk of dementia
(95% CI = 0.22–0.70) (Table 2). Additionally, the RA severity
indices may affect this finding, but the severity data were not
available in the LHID. To address this concern, we undertook two
sensitivity analyses to verify the relationship between RS use and
subsequent dementia risk. The first sensitivity analysis, limited to
those with no comorbidities, found that RS was still protective
against the development of dementia (adjusted HR = 0.57, 95%
CI = 0.39–0.71). Second, we used the prescription of biological
agents as a surrogate for RA severity, dividing them by whether
or not they received biological agents for ≥6 months after the
index date. The proportion of use of biological agents was 61.3%
(592/965) in the RS user cohort and 60.8% (1,193/1,962) in the
non-RS user cohort. After considering the influence of use of
biological agents, RS use was still significantly related to the
lower risk of dementia, with the adjusted HR of 0.56 (95% CI =
0.34–0.76). Accordingly, we inferred that disease severity did not
appreciably confound the relationship obtained in this study.
Table 3 presents the analytic results stratified by age and sex.
Collectively, the use of RS was associated with a lower risk of
dementia, irrespective of sex. The multivariable stratified analysis
further verified a significant association of lower risk of dementia
with RS use among those 50 years and older (aHR = 0.56, 95%
CI = 0.50–0.68). Table 4 indicated that the RS use provided the

0.96

Yes

1682 (85.7)

828 (85.8)

No

280 (14.3)

137 (14.2)

Comorbidity
Hypertension

1059 (54.0)

551 (57.1)

0.11

Stroke

383 (19.5)

212 (22.0)

0.12

Diabetes

663 (33.8)

347 (36.0)

0.25

Heart disease

962 (49.0)

527 (54.6)

0.01

Chronic kidney disease

164 (8.4)

74 (7.7)

0.52

Cancer

280 (14.3)

137 (14.2)

0.96

Alcohol dependence syndrome

18 (0.9)

3 (0.3)

0.07

Tobacco use

43 (2.2)

22 (2.3)

0.88

Numbers indicate n (%) except for mean age.
*Indicating mean value (standard deviation).

(levels 1–2), suburban (levels 3–4) and rural (levels 5–7) areas.
Additionally, based on previous literature (24), the baseline
comorbidity for each person included hypertension (ICD-9CM 401–405), stroke (ICD-9-CM 430–438), diabetes (ICD-9CM 250), heart disease (ICD-9-CM 410–429), chronic kidney
disease (CKD) (ICD-9-CM 585), tobacco use (ICD-9-CM 305.1),
alcohol dependence syndrome (ICD-9-CM 303), and cancer
(ICD-9-CM 140–208). Medication usage was identified based on
whether the enrollees took corticosteroids or disease-modifying
antirheumatic drugs for more than 6 months after the index date.

Statistical Analysis
Firstly, the chi-square test and Student’s t-test were employed
to examine the baseline differences in sociodemographic
characteristics and comorbidities between two groups. The Cox
proportional hazards regression analysis was then applied to
compute the adjusted hazard ratio (HR) with 95% confidence
interval (CI) of dementia risk in association with RS use, after
accounting for confounders reported at baseline, such as the
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TABLE 2 | Crude and adjusted HR for dementia in RA patients who received or did not receive RS.
Patient group

Events

PYs

Incidence*

Non-RS users

HR (95% CI)

P

Adjusted HR** (95% CI)

P

1,224

10604.53

115.42

1

RS users

388

5141.98

75.46

0.64 (0.57–0.71)

<0.001

0.60 (0.53–0.67)

1
<0.001

Low intensity

337

4185.72

80.51

0.69 (0.60–0.76)

<0.001

0.64 (0.57–0.73)

<0.001

Medium intensity

43

794.88

54.10

0.47 (0.35–0.64)

<0.001

0.42 (0.31–0.57)

<0.001

High intensity

8

161.39

49.57

0.43 (0.23–0.72)

0.003

0.38 (0.22–0.70)

0.005

*Incidence rate is per 1,000 PYs.
**Model adjusted for age, sex, urbanization level, monthly income, corticosteroid usage, and comorbidities.

TABLE 3 | Incidence and dementia risk for RA patients with and without RS stratified by sex and age.
Variables

Non-RS users

RS users

Crude HR
(95% CI)

P

Adjusted HR
(95% CI)

P

Case

PYs

Incidence

Case

PY

Incidence

Female

821

6886.45

119.22

300

3953.11

75.89

0.65
(0.55–0.72)

<0.001

0.61γ
(0.53–0.68)

<0.001

Male

403

3718.67

108.39

88

1188.87

74.02

0.67
(0.51–0.75)

<0.001

0.59γ
(0.47–0.73)

<0.001

≤50

540

6102.57

88.49

153

2585.02

59.19

0.68
(0.53–0.77)

<0.001

0.67*
(0.51–0.74)

<0.001

>50

684

4501.95

151.93

235

2556.96

91.92

0.59
(0.52–0.71)

<0.001

0.56*
(0.50–0.68)

<0.001

Sex

Age (years)

Y Model adjusted for age, urbanization level, monthly income, corticosteroid usage, and comorbidities.
*Model adjusted for sex, urbanization level, monthly income, corticosteroid usage, and comorbidities.

decreased the risk of developing dementia even further to 62%.
Examination of the dose-response relationship may help in
clarifying the nature of the causation between RS usage and
the subsequent dementia risk. Despite the paucity of findings
regarding the long-term impact of RS on sequent dementia
risk among individuals with rheumatic disorders, this positive
therapeutic effect observed with use of RS appeared to concurred
with earlier reports and further adds to the literature on this topic
(9, 11–13).
Several explanations have been proposed to explain the
positive effect of RS against the dementia onset in RA patients.
First, participation in physical activity training has been proven
to inhibit the production of inflammatory cytokines in the body,
such as interleukin (IL)-6, IL-1, and tumor necrosis factor-α
(25). Reducing inflammatory markers can not only mitigate
the uncomfortable symptoms of RA but also benefit synaptic
and neuronal integrity, which in turn lessens the individual’s
susceptibility to cognitive impairment disorders. Recent evidence
demonstrated that the above-mentioned inflammatory markers
might play pivotal roles in the development or pathology of
neurodegenerative diseases (26, 27). Second, a previous study
also found the activation of intracellular signaling pathways,
especially brain-derived neurotrophic factor (BDNF)—tyrosine
receptor kinase B (TrkB), may account for the positive link
between RS utilization and lower risk of neurological disorders
(28). Upregulating the BDNF-TrkB pathway has been shown to

TABLE 4 | Risk of dementia in RA patients who used RS relative to those who did
not use RS by length of follow up.
Follow-up

Non-RS users
Adjusted
HR

95% CI

RS users
Adjusted
HR*

95% CI

P

<0.001

<2 years

1

Reference

0.38

0.30–0.48

2–5 years

1

Reference

0.43

0.34–0.50

<0.001

5–10 years

1

Reference

0.64

0.48–0.81

<0.001

>10 years

1

Reference

0.86

0.72–0.95

0.003

*Model adjusted for age, sex, urbanization level, monthly income, corticosteroid usage,
and comorbidities.

greatest benefit when initiated within the first 2 years after RA
onset (adjusted HR = 0.38, 95% CI = 0.30–0.48).

DISCUSSION
Given that RS is becoming more frequently an integral part
of a multidisciplinary approach to RA management, it may be
imperative to determine whether the RS use can lessen the
predisposition of dementia for those affected by RA.
Over the 15-years study period, we found a 40% lower risk of
dementia in those receiving RS than in those not receiving RS.
Notably, after the onset of RA, RS use with the high intensity
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causal relation between the high intensity of RS use and lower
risk of dementia among RA subjects.

rescue neuronal cells from neurodegeneration due to injuries
in the central nervous system and to prevent further oxidative
damage in cultivated neurons (29). Meanwhile, activation of
BDNF-TrkB signaling would facilitate the long-term potentiation
and formation of synapses, by triggering phosphorylation and the
expression of proteins that are markers of synaptic plasticity, thus
lessening the vulnerability to dementia (28).
In addition, findings from the present study revealed that
older patients benefited most from RS by lowering the likelihood
for dementia occurrence. We speculate that, compared to
older adults, younger adults may have fewer coexisting medical
conditions, better medical knowledge, better attitudes toward
health, and are also more likely to comply with medical
or health advices (30). Deficits in any of these areas could
partially reduce the effect of RS on lowering dementia risk.
Altogether, we recommend that an early inclusion of RS to
routine pharmacological therapy, as well as prolonging its use,
may serve to cognitively benefit patients with RA.
While our study is the first to investigate the relation between
RS use and dementia risk among RA patients, there are several
important limitations to consider. First, while using secondary
health care databases, there could be careless errors in the coding
process. To minimize this bias, we enrolled only persons with
new-onset RA or dementia, and only after the patients had at least
three outpatient visits reporting consistent diagnoses or at least
one inpatient admission. It should also be noted that the NHI
of Taiwan randomly reviewed the charts and audited medical
charges to verify the accuracy of claim files (17). Furthermore, the
coding approach and data availability were similar between the
two groups, and the misclassification bias could have likely been
non-differential and toward the null hypothesis, thus possibly
inducing the underestimation of observed estimate. Second, the
LHID lacks information on social network relationships, family
history, laboratory data or educational level. Thus, the study
linking administrative data and the abovementioned factors is
worthy of further investigation. Third, the used database lacks
a reliable severity index of RA, and failure to adjust for this
factor may affect the findings. Nevertheless, we attempted to
adjust for the possible comorbidities via the use of multivariate
statistical analysis of the data and the prescription of biological
agents to avoid confounding as much as possible. Findings from
the two sensitivity analyses supported the present finding that
the RA severity did not mislead the conclusion reported herein.
Fourth, we could not shed further light on the corresponding
effect of specific RS modalities on dementia risk because the fees
regarding RS intervention during healthcare procedures were
integrated and presented in one consolidated file of the NHIRD.
Fifth, the stratification of RS intensity was made arbitrarily, so the
causal relationships implied by our findings should be interpreted
with caution. A randomized controlled trial is recommended
to better determine the efficacy of RS, as well as to uncover
the mechanisms underpinning the positive impact of RS. These
limitations notwithstanding, this study also had considerable
advantages. The database applied in this study is representative
of the entire Taiwanese population, and this large sample size
ensured obtaining reliable findings. In addition, the application
of longitudinal cohort study design could robustly examine the
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CONCLUSION
This study explored the possibility that the use of RS may lessen
the sequent risk of dementia among the individuals with RA,
which could be a reference for further studies regarding RS
influence on other medical complications due to RA. Although
the findings from the current study indicated that use of RS by
RA groups was related to lower dementia risk, future prospective
randomized trials that overcome the limitations of this study are
warranted to provide more conclusive evidence of the association
suggested in this study.
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